Working with the NIDA, NIH and CDC to advance fentanyl overdose and addiction bio tech
Co-founded in 2018 by successful biotech-focused investors and funded via NIH Grants of $7.6M
Tens of Thousands of Americans are Dying Every Year from Fentanyl Overdose It’s time to fight fentanyl like the foe that it is
As a Navy admiral, I helped lead one of the most powerful militaries in the world. Today, our nation is fighting an urgent war right
Cessation Therapeutics’ Anti-Fentanyl Monoclonal Antibody Treatment Shows Promise in Protecting Against Fentanyl-Induced Overdose
Single administration of treatment blocked life-threatening, fentanyl-induced respiratory depression in non-human primates for at least 3 weeks CHAPEL HILL, N.C.–(BUSINESS WIRE)–Cessation Therapeutics (“Cessation”), an early-stage
Cessation Therapeutics Featured in Article “Opioid Vaccines as a Tool to Stem Overdose Deaths”
Cessation Therapeutics, Inc, a preclinical stage biotechnology company focused on developing novel immunotherapeutics and small molecules to treat addiction, was featured in an article in
New From Cessation
Most Popular Stories
Tens of Thousands of Americans are Dying Every Year from Fentanyl Overdose It’s time to fight fentanyl like the foe that it is
As a Navy admiral, I helped lead one of the most powerful militaries in the world. Today, our nation is fighting an urgent war right
Cessation Therapeutics’ Anti-Fentanyl Monoclonal Antibody Treatment Shows Promise in Protecting Against Fentanyl-Induced Overdose
Single administration of treatment blocked life-threatening, fentanyl-induced respiratory depression in non-human primates for at least 3 weeks CHAPEL HILL, N.C.–(BUSINESS WIRE)–Cessation Therapeutics (“Cessation”), an early-stage
Cessation Therapeutics Featured in Article “Opioid Vaccines as a Tool to Stem Overdose Deaths”
Cessation Therapeutics, Inc, a preclinical stage biotechnology company focused on developing novel immunotherapeutics and small molecules to treat addiction, was featured in an article in